<DOC>
	<DOC>NCT00090012</DOC>
	<brief_summary>The purposes of this study are to determine: - The effectiveness of olanzapine as compared to quetiapine in treating and preventing the recurrence of a variety of symptoms of schizophrenia and schizoaffective disorder in patients who are obese or overweight. - The safety of olanzapine as compared to quetiapine.</brief_summary>
	<brief_title>Comparison of Continuing Olanzapine to Switching to Quetiapine in Overweight or Obese Patients With Schizophrenia and Schizoaffective Disorder</brief_title>
	<detailed_description />
	<mesh_term>Disease</mesh_term>
	<mesh_term>Schizophrenia</mesh_term>
	<mesh_term>Overweight</mesh_term>
	<mesh_term>Psychotic Disorders</mesh_term>
	<mesh_term>Quetiapine Fumarate</mesh_term>
	<mesh_term>Olanzapine</mesh_term>
	<criteria>You must be 1875 years of age and be diagnosed with schizophrenia or schizoaffective disorder You must be able to visit the doctor's office thirteen (13) times over a twentysix (26) week period You are a woman and are pregnant or breastfeeding You have an acute or unstable medical illness, such as heart, liver, or kidney disease, or you have a seizure disorder. (Note: If you are uncertain about a particular condition, please discuss it with your physician.) You have a history of allergic reaction or intolerance to olanzapine or quetiapine</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>November 2007</verification_date>
</DOC>